5 Best Upside Stocks To Buy Now

2. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Latest Share Price Upside: 69%

Number of Q3 2023 Hedge Fund Investors: 50

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology company developing treatments for rare and genetic disorders. The firm’s share price gained double digit percentage points in November after the Food and Drug Administration (FDA) cleared a drug to start trials for muscle disorders.

Insider Monkey scoured through 910 hedge funds for their September quarter of 2023 shareholdings to find that 50 had invested in the company. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s biggest hedge fund shareholder is Kurt Von Emster’s VenBio Select Advisor due to its $487 million investment.

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)